Federal Register / Vol. 75, No. 192 / Tuesday, October 5, 2010 / Notices 61505 

international standards, as an 

instrumental and essential prerequisite 

to the establishment and effective 

implementation of adequate and 

appropriate legislation covering all 

aspects of products for veterinary use, 

including registration, quality control, 

distribution, monitoring of quantities 

and final use. 

• Develop and improve international 

and regional cooperation in the 

establishment and enforcement of 

legislation to harmonize the regulatory 

framework between OIE Member States 

so as to assist countries in need to 

effectively institute and maintain such 

mechanisms. 

• Encourage countries to allocate 

appropriate human and financial 

resources to veterinary services and 

laboratories to correctly implement the 

OIE standards and guidelines related to 

veterinary products and their control. 

• Enhance capacities of national focal 

points for OIE on matters related to 

veterinary products according to the 

suggested terms of reference and 

encourage his/her participation in 

training sessions and appropriate 

international gatherings and meetings. 

• Promote the responsible and 

prudent use of veterinary medicinal 

products, in particular of antimicrobials 

used in veterinary medicine, and the 

monitoring of the quantities used and 

potential existence or development of 

antimicrobial resistance in diseasecausing organisms affecting both 

humans and animals. 

• Actively encourage the recognition 

and application of the international 

recommendations, guidelines and tools 

developed by the OIE and adopted by 

the World Assembly of Delegates on 

veterinary products. 

C. Eligibility Information 

The following organizations/ 

institutions are eligible to apply: The 

OIE. 

II. Award Information/Funds Available 

A. Award Amount 

FDA anticipates providing one award 

of $565,000 (total costs including 

indirect costs) in fiscal year (FY) 2010 

in support of this project. Subject to the 

availability of funds and successful 

performance, 1 additional year of 

support up to $565,000 per year will be 

available. 

B. Length of Support 

The support will be 1 year with the 

possibility of an additional year of 

noncompetitive support. Continuation 

beyond the first year will be based on 

satisfactory performance during the 

preceding year, receipt of a noncompeting continuation application and 

available Federal FY appropriations. 

Dated: September 29, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–24905 Filed 10–4–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Notice of Listing of Members of the 

National Institutes of Health’s Senior 

Executive Service 2010 Performance 

Review Board (PRB) 

The National Institutes of Health 

(NIH) announces the persons who will 

serve on the National Institutes of 

Health’s Senior Executive Service 2010 

Performance Review Board. This action 

is being taken in accordance with Title 

5, U.S.C., 4314(c)(4), which requires that 

members of performance review boards 

be appointed in a manner to ensure 

consistency, stability, and objectivity in 

performance appraisals and requires 

that notice of the appointment of an 

individual to serve as a member be 

published in the Federal Register. 

The following persons will serve on 

the NIH Performance Review Board, 

which oversees the evaluation of 

performance appraisals of NIH Senior 

Executive Service (SES) members: 

Ms. Colleen Barros (Chair), Dr. Michael 

Gottesman, Ms. Lenora Johnson, Ms. 

Robin Kawazoe, Dr. Sally Rockey, Dr. 

Lawrence Tabak, Dr. Samir Zakhari. 

For further information about the NIH 

Performance Review Board, contact the 

Office of Human Resources, Workforce 

Relations Division, National Institutes of 

Health, Building 31, Room B3C07, 

Bethesda, Maryland 20892, telephone 

301–402–9203 (not a toll-free number). 

Dated: September 27, 2010. 

Francis S. Collins, 

Director, National Institutes of Health. 

[FR Doc. 2010–24929 Filed 10–4–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee to the Director 

(ACD), Centers for Disease Control and 

Prevention (CDC)—Health Disparities 

Subcommittee (HDS) 

Correction: This notice was published 

in the Federal Register on September 1, 

2010, Volume 75, Number 169, page 

53703. A quorum of the subcommittee’s 

membership was not able to participate; 

therefore, the meeting was adjourned. 

The subcommittee will reconvene as 

follows: 

Time and Date: 2 p.m.–3 p.m., 

October 21, 2010. 

Place: Teleconference. 

Status: Open to the public. 

Teleconference access limited only by 

the availability of telephone ports. The 

public is welcome to participate during 

the public comment period, which is 

tentatively scheduled from 2:45 p.m. to 

2:50 p.m. To participate in the 

teleconference please dial (877) 394– 

7734 and enter conference code 

9363147. 

Purpose: The Subcommittee will 

provide recommendations for 

consideration to the ACD on strategic 

and other broad issues facing CDC. 

Matters To Be Discussed: Policy brief 

on health equity and social 

determinants of health; update on 

collaboration with the CDC Health 

Equity Workgroup; CDC Director’s 

Annual Health Disparity Report; and 

briefing on the realignment of the CDC 

Office of Minority Health and Health 

Disparities. Agenda items are subject to 

change as priorities dictate. 

Contact Person for More Information: 

Walter W. Williams, M.D., M.P.H., 

Designated Federal Officer, HDS, ACD, 

CDC, 1600 Clifton Road, NE., M/S E–67, 

Atlanta, Georgia 30333. Telephone (404) 

498–2310, E-mail: http:// 

www1@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 29, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–24911 Filed 10–4–10; 8:45 am] 

BILLING CODE 4163–18–P 

mstockstill on DSKH9S0YB1PROD with NOTICES